# ABEONA THERAPEUTICS INC.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/abeona-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 26 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T13:52:50.363049+00:00 |
| Last reviewed | 2026-10-16T13:52:50.363049+00:00 |

## Identity

- Legal name: ABEONA THERAPEUTICS INC.
- Display name: ABEONA THERAPEUTICS INC.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T17:09:25.110623+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.844 |
| Directors | 9 |
| Committees | 6 |
| Governance events | 19 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Bernhardt G. Zeiher, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:5
- Christine Silverstein: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:6
- Donald A. Wuchterl: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7
- Eric Crombez, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:8
- Faith L. Charles: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9
- Leila Alland, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:10
- Mark J. Alvino: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11
- Michael Amoroso: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:12
- Vishwas Seshadri, Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:13

## Committees

- Audit (audit). Chair: Mark J. Alvino. Members: Mark J. Alvino (chair, current); Donald A. Wuchterl (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:audit
- Audit · Chair; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Mark J. Alvino (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:audit-chair-compensation-chair
- Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Donald A. Wuchterl (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:audit-nominating-and-governance
- Compensation (compensation). Chair: Mark J. Alvino. Members: Mark J. Alvino (chair, current); Faith L. Charles (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:compensation
- Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Faith L. Charles (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:compensation-nominating-and-governance-chair
- Nominating and Governance (nominating_governance). Chair: Faith L. Charles. Members: Faith L. Charles (chair, current); Donald A. Wuchterl (member, current). committee_id=alpha:committee:abeona-therapeutics-inc:nominating-and-governance

## Executive leadership

- Brendan O'Malley: Chief Legal Officer [GC]. Status: current. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:14
- Joseph Vazzano: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:15
- Madhav Vasanthavada: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:16
- Vishwas Seshadri: President and Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:17

## Governance events

- GC_CHANGED: Brendan O'Malley executive of ABEONA THERAPEUTICS INC., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:10n8ocgdbfdn6
- CFO_CHANGED: Joseph Vazzano executive of ABEONA THERAPEUTICS INC., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:p6bze65hjmkk
- EXECUTIVE_APPOINTED: Madhav Vasanthavada executive of ABEONA THERAPEUTICS INC., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:138ulznt3a1nx
- CEO_CHANGED: Vishwas Seshadri executive of ABEONA THERAPEUTICS INC., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:dmpbto4fknk2
- DIRECTOR_APPOINTED: Bernhardt G. Zeiher, M.D. seat on ABEONA THERAPEUTICS INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1adw7xufxlvwe
- DIRECTOR_APPOINTED: Eric Crombez, M.D. seat on ABEONA THERAPEUTICS INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1qsbaw97w3ouv
- DIRECTOR_APPOINTED: Donald A. Wuchterl seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1c512b71i5k0ut
- DIRECTOR_APPOINTED: Faith L. Charles seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:kdn2snzo0lvj
- DIRECTOR_APPOINTED: Leila Alland, M.D. seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:s7az79r3mygj
- DIRECTOR_APPOINTED: Mark J. Alvino seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1rejtri1biw6mm
- DIRECTOR_APPOINTED: Michael Amoroso seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:nr1o9fnxt3e1
- DIRECTOR_APPOINTED: Vishwas Seshadri, Ph.D. seat on ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1r5ujyq3eg1jk
- COMMITTEE_CREATED: Audit · Chair; Compensation · Chair committee of ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1t0gdb01rw090a
- COMMITTEE_MEMBER_ADDED: Mark J. Alvino member of Audit · Chair; Compensation · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:76jwmf1sv3p4b
- COMMITTEE_CREATED: Audit; Nominating and Governance committee of ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:17b9cml14g2a1t
- COMMITTEE_MEMBER_ADDED: Donald A. Wuchterl member of Audit; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:pch40t1978pen
- COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of ABEONA THERAPEUTICS INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:msqz331gyrp1b
- COMMITTEE_MEMBER_ADDED: Faith L. Charles member of Compensation; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:5kzj8c1innuw8
- DIRECTOR_APPOINTED: Christine Silverstein seat on ABEONA THERAPEUTICS INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:vyfcn919vfuap

## Scoped resources

- `alpha://company/abeona-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record
- `alpha://company/abeona-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=identity
- `alpha://company/abeona-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/abeona-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=board
- `alpha://company/abeona-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=committees
- `alpha://company/abeona-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=leadership
- `alpha://company/abeona-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=ownership
- `alpha://company/abeona-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=financials
- `alpha://company/abeona-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/abeona-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=compensation
- `alpha://company/abeona-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=governance
- `alpha://company/abeona-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/abeona-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=audit
- `alpha://company/abeona-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=legal
- `alpha://company/abeona-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=risk
- `alpha://company/abeona-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=cyber
- `alpha://company/abeona-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/abeona-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=agents
- `alpha://company/abeona-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/abeona-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=events
- `alpha://company/abeona-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=relationships
- `alpha://company/abeona-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=assessments
- `alpha://company/abeona-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:mark-j-alvino","name":"Mark J. Alvino"},"source_id":"board_seats"}`
- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:donald-a-wuchterl","name":"Donald A. Wuchterl"},"source_id":"board_seats"}`
- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:mark-j-alvino","name":"Mark J. Alvino"},"source_id":"board_seats"}`
- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:faith-l-charles","name":"Faith L. Charles"},"source_id":"board_seats"}`
- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:faith-l-charles","name":"Faith L. Charles"},"source_id":"board_seats"}`
- Claim alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:donald-a-wuchterl","name":"Donald A. Wuchterl"},"source_id":"board_seats"}`

## Leadership

- Bernhardt G. Zeiher, M.D.: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Christine Silverstein: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Donald A. Wuchterl: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Eric Crombez, M.D.: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Faith L. Charles: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Leila Alland, M.D.: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Mark J. Alvino: Director, Audit · Chair; Compensation · Chair. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Michael Amoroso: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Vishwas Seshadri, Ph.D.: Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:13. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7.
- Brendan O'Malley: Chief Legal Officer. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:14. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5b138bc3469f7bc49c5111ee29d91334e56d011c4068ac584352839848ab1331.
- Joseph Vazzano: Chief Financial Officer. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:15. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b890951581e1979438de2a1784b93aa1cb5b80ef5a35584ca7d555f4073167ee.
- Madhav Vasanthavada: Chief Commercial Officer. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:16. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:26ef7aab72d421c2c44b9918b801602a65aa8d23e4ffe0cce80d9e8d0e3219da.
- Vishwas Seshadri: President and Chief Executive Officer and Director. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:17. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fe0e2a601d3e8e4b7c4a16b07caa611ed5f1a21940cb2c3f12b1c6ab80d1286d.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Mark J. Alvino; Members Mark J. Alvino (Chair); Donald A. Wuchterl. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Compensation: Chair Mark J. Alvino; Members Mark J. Alvino (Chair); Faith L. Charles. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Nominating and Governance: Chair Faith L. Charles; Members Faith L. Charles (Chair); Donald A. Wuchterl. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- ABEONA THERAPEUTICS INC.. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35d45103482303da8a724a97b2bbf5655bdc4b02b3ecd65eebfad7aadee53e1.

## Entity Status

- Public listing published. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35d45103482303da8a724a97b2bbf5655bdc4b02b3ecd65eebfad7aadee53e1.

## Published Fact

- US. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35d45103482303da8a724a97b2bbf5655bdc4b02b3ecd65eebfad7aadee53e1.

## Committee Appointment

- Mark J. Alvino: chair, Audit. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Donald A. Wuchterl: member, Audit. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Mark J. Alvino: chair, Compensation. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Faith L. Charles: member, Compensation. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Faith L. Charles: chair, Nominating and Governance. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.
- Donald A. Wuchterl: member, Nominating and Governance. Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f.

## Security Listing

- ABEO (NASDAQ). Claim: alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e35d45103482303da8a724a97b2bbf5655bdc4b02b3ecd65eebfad7aadee53e1.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:e35d45103482303da8a724a97b2bbf5655bdc4b02b3ecd65eebfad7aadee53e1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/abeona-therapeutics-inc).
- alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7: [ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09](https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm).
- alpha:projection-evidence:document:5b138bc3469f7bc49c5111ee29d91334e56d011c4068ac584352839848ab1331: [ABEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm).
- alpha:projection-evidence:document:b890951581e1979438de2a1784b93aa1cb5b80ef5a35584ca7d555f4073167ee: [ABEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm).
- alpha:projection-evidence:document:26ef7aab72d421c2c44b9918b801602a65aa8d23e4ffe0cce80d9e8d0e3219da: [ABEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm).
- alpha:projection-evidence:document:fe0e2a601d3e8e4b7c4a16b07caa611ed5f1a21940cb2c3f12b1c6ab80d1286d: [ABEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm).
- alpha:projection-evidence:36c4604449bbed15862f92764ed5f469892c8e1d71d7e1303be45de2082bdd3f: [Audit](https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/abeona-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/abeona-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/abeona-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-16T17:09:24.884982+00:00; recorded 2026-10-16T17:09:24.884982+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.